2BBBullish & Bearish
Health Care

Dr. Reddy's Laboratories Ltd Common Stock (RDY) Stock Score & Signals

Dr. Reddy's Laboratories Ltd Common Stock (RDY) trades on NYSE. It operates in the Health Care sector, Drug Manufacturers - Specialty & Generic industry. Its current 2BB score is 58 out of 100.

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr.

2BB score and signals

Dr. Reddy's Laboratories Ltd Common Stock’s current 2BB score is 58 out of 100, built from the signal categories below.

SignalScoreReading
Activity60Moderate
Momentum61Improving
Financial strength61Strong
Quality100Very Strong
Risk55Moderate

Company facts

CEOErez Israeli
HeadquartersHyderabad, Andhra Pradesh, India
Founded1984
Employees27.5K
P/E ratio29.20
52-week range$11.36 – $15.67

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2027-01-1912.0666$88.52B
2026-10-229.6519$83.44B
2026-07-229.1698$82.62B
2026-05-122.6511.4028$75.46B$84.10B